Zobrazeno 1 - 10
of 11
pro vyhledávání: '"365"'
Autor:
Juan Carlos Hernández-Boluda, Estela Giménez, Eva M. Mateo, José Luis Piñana, Carlos Solano, Marc Poch, Eliseo Albert, Montserrat Gómez, Ariadna Pérez, David Navarro, Rosa Goterris, Paula Amat
Publikováno v:
Bone Marrow Transplantation. 54:90-98
To gauge the risk of delaying initiation of prophylaxis with letermovir from the time of donor infusion to prevent CMV infection in allo-HSCT recipients we investigated the clinical outcomes of CMV DNAemia episodes occurring before engraftment, and c
Autor:
L. C.-L. Lim, Mary E.D. Flowers, Jan Storek, Michael Boeckh, Robert P. Witherspoon, Monja A. Dawson, D.G. Maloney, B. E. Burman, Terry Stevens-Ayers, F. Viganego, M. M. P. T. Herremans
Publikováno v:
Bone marrow transplantation. 33(3)
Allogeneic hematopoietic cell transplantation is followed by humoral immunodeficiency. We evaluated whether antibody levels can be improved by recipient vaccination on day -1 and 50 and whether the levels can be further improved by donor vaccination
Autor:
Marcie L. Riches, Kwang Woo Ahn, Amelia Langston, Hillard M. Lazarus, Min Chen, David I. Marks, Genofeva A. Papanicolou, John R. Wingard, Rodrigo Martino, Charles L. Bennett, Richard T. Maziarz, Jo Anne H. Young, Steven Trifilio
Publikováno v:
Bone marrow transplantation
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Risk factors for non-Aspergillus mold infection (NAMI) and the impact on transplant outcome are poorly assessed in the current era of antifungal agents. Outcomes of 124 patients receiving allogeneic hematopoietic cell transplantation (HCT) diagnosed
Autor:
Diane George, Zhezhen Jin, Prakash Satwani, James Garvin, Matthew Hall, Wallace Bourgeois, Angela Ricci, Monica Bhatia
Publikováno v:
Bone marrow transplantation. 54(5)
The costs associated with allogeneic hematopoietic cell transplantation (alloHCT) are high. Differences in costs and healthcare utilization among potential donor sources for alloHCT are not well characterized in pediatric recipients of alloHCT. One p
Publikováno v:
Bone marrow transplantation. 52(11)
Immune recovery (IR) after haploidentical stem cell transplantation (haplo-SCT) in severe aplastic anemia (SAA) patients remains relatively unknown. In this study, we examined immune cell subset counts and immunoglobulins in 81 SAA patients from day
Autor:
Mark B. Geyer, R. Hawks, M T Lee, Erin Morris, Joseph Schwartz, Prakash Satwani, M Licursi, Mitchell S. Cairo, Courtney Baker, G. Del Toro, Elana Smilow, Warren A. Zuckerman, D. George, Kavita Radhakrishnan, Monica Bhatia, Zhezhen Jin, James Garvin, L.A. Baxter-Lowe
Publikováno v:
Bone Marrow Transplantation. 49:913-920
BU and CY (BU/CY; 200 mg/kg) before HLA-matched sibling allo-SCT in children with sickle cell disease (SCD) is associated with ~85% EFS but is limited by the acute and late effects of BU/CY myeloablative conditioning. Alternatives include reduced tox
Autor:
Ana García-Noblejas, Carlos Solano, Jose B Nieto, R de la Cámara, Juan C. Hernández-Boluda, I Benet, M J Remigia, María Ángeles Clari, Elisa Costa, Nuria Tormo, David Navarro, Javier María García López, Beatriz Muñoz-Cobo
Publikováno v:
Bone Marrow Transplantation. 46:1437-1443
Threshold levels of CMV-specific T-cell populations presumably affording protection from active CMV infection in allo-SCT recipients have been proposed, but lack extensive validation. We quantified CMV pp65 and immediate-early 1-specific IFN-γ CD8(+
Publikováno v:
Bone marrow transplantation. 49(4)
Following hematopoietic SCT (HSCT) for non-malignant disorders (NMDs) variable donor chimerism among lympho-hematopoietic lines may be observed. We retrospectively evaluated early post-HSCT, lineage-sorted (CD3+ and CD15+) peripheral blood leukocyte
Autor:
Jennifer A. Oberg, Julia L. Glade Bender, James Garvin, Mitchell S. Cairo, Charles E. Basch, Erin Morris, Lauren Harrison, Stephen A. Sands
Publikováno v:
Bone marrow transplantation. 48(6)
The objective of this study was prospectively to investigate the health-related quality of life (HRQOL) of 80 pediatric recipients of allo-SCT for malignant and non-malignant diseases. The PedsQL 4.0 was used to assess self-reported physical, emotion
Autor:
S. A. Abhyankar, K. Godder, Rudolph S. Parrish, Linda J. Hazlett, W.G. Harris, Lee C, Pati Ar, Adrian P. Gee, S.S. Geier, M W Turner, Lawrence S. Lamb, Henslee-Downey Pj
Publikováno v:
Bone marrow transplantation. 21(5)
Myeloablative chemotherapy followed by transplantation of a T cell-depleted bone marrow graft from a partially mismatched related donor provides a potentially curative option for patients with leukemia and other disorders of hematopoiesis, although t